Is GE HealthCare Stock a Good Investment?
GE HealthCare Investment Advice | GEHC |
- Examine GE HealthCare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research GE HealthCare's leadership team and their track record. Good management can help GE HealthCare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact GE HealthCare's business and its evolving consumer preferences.
- Compare GE HealthCare's performance and market position to its competitors. Analyze how GE HealthCare is positioned in terms of product offerings, innovation, and market share.
- Check if GE HealthCare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about GE HealthCare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in GE HealthCare Technologies stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if GE HealthCare Technologies is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine GE HealthCare Stock
Researching GE HealthCare's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 72.0% of the company shares are owned by institutional investors. The company last dividend was issued on the 18th of April 2024.
To determine if GE HealthCare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding GE HealthCare's research are outlined below:
About 72.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: GE HealthCare Technologies Has Some Way To Go To Become A Multi-Bagger |
GE HealthCare Quarterly Cost Of Revenue |
|
GE HealthCare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in GE HealthCare Technologies. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to GE HealthCare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024 Upcoming Quarterly Report | View | |
23rd of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
6th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact GE HealthCare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises GE HealthCare's investors have experienced.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-10-31 | 2023-09-30 | 0.9 | 0.99 | 0.09 | 10 | ||
2024-02-06 | 2023-12-31 | 1.07 | 1.18 | 0.11 | 10 | ||
2023-01-30 | 2022-12-31 | 1.06 | 1.31 | 0.25 | 23 |
GE HealthCare Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. GEHC target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. GE HealthCare's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
15 | Strong Buy |
Most GEHC analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand GEHC stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of GE HealthCare Techno, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGE HealthCare Target Price Projection
GE HealthCare's current and average target prices are 81.20 and 88.00, respectively. The current price of GE HealthCare is the price at which GE HealthCare Technologies is currently trading. On the other hand, GE HealthCare's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On GE HealthCare Target Price
GE HealthCare Analyst Ratings
GE HealthCare's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about GE HealthCare stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of GE HealthCare's financials, market performance, and future outlook by experienced professionals. GE HealthCare's historical ratings below, therefore, can serve as a valuable tool for investors.GE HealthCare's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 37.12 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GE HealthCare's market, we take the total number of its shares issued and multiply it by GE HealthCare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
GE HealthCare's profitablity analysis
GE HealthCare's profitability indicators refer to fundamental financial ratios that showcase GE HealthCare's ability to generate income relative to its revenue or operating costs. If, let's say, GE HealthCare is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GE HealthCare's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GE HealthCare's profitability requires more research than a typical breakdown of GE HealthCare's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.09 | 0.17 | |
Return On Capital Employed | 0.10 | 0.14 | |
Return On Assets | 0.05 | 0.08 | |
Return On Equity | 0.22 | 0.14 |
Determining GE HealthCare's profitability involves analyzing its financial statements and using various financial metrics to determine if GE HealthCare is a good buy. For example, gross profit margin measures GE HealthCare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of GE HealthCare's profitability and make more informed investment decisions.
The data published in GE HealthCare's official financial statements usually reflect GE HealthCare's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of GE HealthCare Techno. For example, before you start analyzing numbers published by GEHC accountants, it's critical to develop an understanding of what GE HealthCare's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of GE HealthCare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, GE HealthCare's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in GE HealthCare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of GE HealthCare Technologies. Please utilize our Beneish M Score to check the likelihood of GE HealthCare's management manipulating its earnings.
Evaluate GE HealthCare's management efficiency
GE HealthCare Techno has return on total asset (ROA) of 0.0563 % which means that it generated a profit of $0.0563 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2239 %, meaning that it created $0.2239 on every $100 dollars invested by stockholders. GE HealthCare's management efficiency ratios could be used to measure how well GE HealthCare manages its routine affairs as well as how well it operates its assets and liabilities. At present, GE HealthCare's Return On Capital Employed is projected to slightly decrease based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.08, whereas Return On Equity is forecasted to decline to 0.14. At present, GE HealthCare's Intangibles To Total Assets are projected to slightly decrease based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.32, whereas Total Assets are forecasted to decline to about 30.4 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | 15.68 | 28.96 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | (15.12) | (14.36) | |
Enterprise Value Over EBITDA | 12.11 | 7.62 | |
Price Book Value Ratio | 4.93 | 5.18 | |
Enterprise Value Multiple | 12.11 | 7.62 | |
Price Fair Value | 4.93 | 5.18 | |
Enterprise Value | 30 B | 26.6 B |
The analysis of GE HealthCare's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze GE HealthCare's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of GEHC Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0015 | Forward Dividend Yield 0.0015 | Forward Dividend Rate 0.12 |
Basic technical analysis of GEHC Stock
As of the 8th of May, GE HealthCare owns the Standard Deviation of 2.71, semi deviation of 2.78, and Market Risk Adjusted Performance of (0.38). GE HealthCare Technologies technical analysis makes it possible for you to employ past data patterns with the intention to determine a pattern that calculates the direction of the firm's future prices. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume patterns, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for GE HealthCare, which can be compared to its peers in the sector. Please check out GE HealthCare Techno jensen alpha, semi variance, and the relationship between the standard deviation and value at risk to decide if GE HealthCare Technologies is priced more or less accurately, providing market reflects its prevailing price of 81.2 per share. Given that GE HealthCare Techno has jensen alpha of 0.2037, we strongly advise you to confirm GE HealthCare's latest market performance to make sure the company can sustain itself sooner or later.GE HealthCare's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GE HealthCare insiders, such as employees or executives, is commonly permitted as long as it does not rely on GE HealthCare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GE HealthCare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Oneill Kevin Michael over three months ago Acquisition by Oneill Kevin Michael of 6507 shares of GE HealthCare subject to Rule 16b-3 | ||
Stacherski Kenneth R over six months ago Payment of 7157 shares by Stacherski Kenneth R of GE HealthCare subject to Rule 16b-3 | ||
Westrick Thomas J over six months ago Acquisition by Westrick Thomas J of 5464 shares of GE HealthCare subject to Rule 16b-3 | ||
Oneill Kevin Michael over six months ago Payment of 1532 shares by Oneill Kevin Michael of GE HealthCare subject to Rule 16b-3 | ||
Rott Roland over six months ago Sale by Rott Roland of 2473 shares of GE HealthCare | ||
Newcomb George A over a year ago Acquisition by Newcomb George A of 143 shares of GE HealthCare subject to Rule 16b-3 | ||
Newcomb George A over a year ago Acquisition by Newcomb George A of 1328 shares of GE HealthCare subject to Rule 16b-3 |
Understand GE HealthCare's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing GE HealthCare's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | 0.0502 | |||
Market Risk Adjusted Performance | (0.38) | |||
Mean Deviation | 1.54 | |||
Semi Deviation | 2.78 | |||
Downside Deviation | 2.95 | |||
Coefficient Of Variation | 1468.57 | |||
Standard Deviation | 2.71 | |||
Variance | 7.36 | |||
Information Ratio | 0.0403 | |||
Jensen Alpha | 0.2037 | |||
Total Risk Alpha | (0.11) | |||
Sortino Ratio | 0.0371 | |||
Treynor Ratio | (0.39) | |||
Maximum Drawdown | 25.93 | |||
Value At Risk | (1.87) | |||
Potential Upside | 3.13 | |||
Downside Variance | 8.71 | |||
Semi Variance | 7.7 | |||
Expected Short fall | (1.63) | |||
Skewness | (1.17) | |||
Kurtosis | 16.15 |
Risk Adjusted Performance | 0.0502 | |||
Market Risk Adjusted Performance | (0.38) | |||
Mean Deviation | 1.54 | |||
Semi Deviation | 2.78 | |||
Downside Deviation | 2.95 | |||
Coefficient Of Variation | 1468.57 | |||
Standard Deviation | 2.71 | |||
Variance | 7.36 | |||
Information Ratio | 0.0403 | |||
Jensen Alpha | 0.2037 | |||
Total Risk Alpha | (0.11) | |||
Sortino Ratio | 0.0371 | |||
Treynor Ratio | (0.39) | |||
Maximum Drawdown | 25.93 | |||
Value At Risk | (1.87) | |||
Potential Upside | 3.13 | |||
Downside Variance | 8.71 | |||
Semi Variance | 7.7 | |||
Expected Short fall | (1.63) | |||
Skewness | (1.17) | |||
Kurtosis | 16.15 |
Consider GE HealthCare's intraday indicators
GE HealthCare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GE HealthCare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daily Balance Of Power | (9,223,372,036,855) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 81.2 | |||
Day Typical Price | 81.2 | |||
Price Action Indicator | (0.12) | |||
Period Momentum Indicator | (0.23) |
GE HealthCare Corporate Filings
F4 | 2nd of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 30th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
4th of April 2024 Other Reports | ViewVerify | |
13A | 2nd of April 2024 An amended filing to the original Schedule 13G | ViewVerify |
GEHC Stock media impact
Far too much social signal, news, headlines, and media speculation about GE HealthCare that are available to investors today. That information is available publicly through GEHC media outlets and privately through word of mouth or via GEHC internal channels. However, regardless of the origin, that massive amount of GEHC data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of GE HealthCare news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of GE HealthCare relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to GE HealthCare's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive GE HealthCare alpha.
GE HealthCare Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards GE HealthCare can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
GE HealthCare Techno Historical Investor Sentiment
Investor biases related to GE HealthCare's public news can be used to forecast risks associated with an investment in GEHC. The trend in average sentiment can be used to explain how an investor holding GEHC can time the market purely based on public headlines and social activities around GE HealthCare Technologies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
GE HealthCare's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for GE HealthCare and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average GE HealthCare news discussions. The higher the estimate score, the more favorable the investor's outlook on GE HealthCare.
Be your own money manager
Our tools can tell you how much better you can do entering a position in GE HealthCare without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
All Next | Launch Module |
GE HealthCare Corporate Executives
Elected by the shareholders, the GE HealthCare's board of directors comprises two types of representatives: GE HealthCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GEHC. The board's role is to monitor GE HealthCare's management team and ensure that shareholders' interests are well served. GE HealthCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GE HealthCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
James Saccaro | VP CFO | Profile |
How to buy GEHC Stock?
To provide specific investment advice or recommendations on GE HealthCare Technologies stock, we recommend investors consider the following general factors when evaluating GE HealthCare Technologies. This will help you to make an informed decision on whether to include GE HealthCare in one of your diversified portfolios:- Examine GE HealthCare's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research GE HealthCare's leadership team and their track record. Good management can help GE HealthCare navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact GE HealthCare's business and its evolving consumer preferences.
- Compare GE HealthCare's performance and market position to its competitors. Analyze how GE HealthCare is positioned in terms of product offerings, innovation, and market share.
- Check if GE HealthCare pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about GE HealthCare's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in GE HealthCare Technologies stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if GE HealthCare Technologies is a good investment.
Already Invested in GE HealthCare Technologies?
The danger of trading GE HealthCare Technologies is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of GE HealthCare is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than GE HealthCare. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile GE HealthCare Techno is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether GE HealthCare Techno offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of GE HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ge Healthcare Technologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ge Healthcare Technologies Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GE HealthCare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the GE HealthCare Techno information on this page should be used as a complementary analysis to other GE HealthCare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for GEHC Stock analysis
When running GE HealthCare's price analysis, check to measure GE HealthCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GE HealthCare is operating at the current time. Most of GE HealthCare's value examination focuses on studying past and present price action to predict the probability of GE HealthCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GE HealthCare's price. Additionally, you may evaluate how the addition of GE HealthCare to your portfolios can decrease your overall portfolio volatility.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is GE HealthCare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GE HealthCare. If investors know GEHC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GE HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.976 | Dividend Share 0.12 | Earnings Share 3.44 | Revenue Per Share 42.799 | Quarterly Revenue Growth (0.01) |
The market value of GE HealthCare Techno is measured differently than its book value, which is the value of GEHC that is recorded on the company's balance sheet. Investors also form their own opinion of GE HealthCare's value that differs from its market value or its book value, called intrinsic value, which is GE HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GE HealthCare's market value can be influenced by many factors that don't directly affect GE HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between GE HealthCare's value and its price, as these two are different measures arrived at by various means. Investors typically determine if GE HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GE HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.